U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C22H23FN4
Molecular Weight 362.4432
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of REVAPRAZAN

SMILES

CC1N(CCC2=C1C=CC=C2)C3=NC(NC4=CC=C(F)C=C4)=NC(C)=C3C

InChI

InChIKey=LECZXZOBEZITCL-UHFFFAOYSA-N
InChI=1S/C22H23FN4/c1-14-15(2)24-22(25-19-10-8-18(23)9-11-19)26-21(14)27-13-12-17-6-4-5-7-20(17)16(27)3/h4-11,16H,12-13H2,1-3H3,(H,24,25,26)

HIDE SMILES / InChI
Molecular Formula C22H23FN4
Molecular Weight 362.4432
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:14:35 UTC 2023
Edited
by admin
on Fri Dec 15 16:14:35 UTC 2023
Record UNII
5P184180P5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
REVAPRAZAN
INN   MART.   MI   WHO-DD  
INN  
Official Name English
SB-641257
Code English
REVAPRAZAN [MART.]
Common Name English
REVAPRAZAN [MI]
Common Name English
YH-1885 FREE BASE
Code English
4-(3,4-DIHYDRO-1-METHYL-2(1H)-ISOQUINOLINYL)-N-(4-FLUOROPHENYL)-5,6-DIMETHYL-2-PYRIMIDINAMINE
Systematic Name English
N-(4-FLUOROPHENYL)-5,6-DIMETHYL-4-(1-METHYL-3,4-DIHYDROISOQUINOLIN-2(1H)-YL)PYRIMIDIN-2-AMINE, (±)-
Systematic Name English
N-(4-FLUOROPHENYL)-5,6-DIMETHYL-4-((1RS)-1-METHYL-3,4-DIHYDROISOQUINOLIN-2(1H)-YL)PYRIMIDIN-2-AMINE
Systematic Name English
revaprazan [INN]
Common Name English
Revaprazan [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29701
Created by admin on Fri Dec 15 16:14:35 UTC 2023 , Edited by admin on Fri Dec 15 16:14:35 UTC 2023
Code System Code Type Description
DRUG CENTRAL
3525
Created by admin on Fri Dec 15 16:14:35 UTC 2023 , Edited by admin on Fri Dec 15 16:14:35 UTC 2023
PRIMARY
EPA CompTox
DTXSID10870216
Created by admin on Fri Dec 15 16:14:35 UTC 2023 , Edited by admin on Fri Dec 15 16:14:35 UTC 2023
PRIMARY
FDA UNII
5P184180P5
Created by admin on Fri Dec 15 16:14:35 UTC 2023 , Edited by admin on Fri Dec 15 16:14:35 UTC 2023
PRIMARY
MERCK INDEX
m9561
Created by admin on Fri Dec 15 16:14:35 UTC 2023 , Edited by admin on Fri Dec 15 16:14:35 UTC 2023
PRIMARY Merck Index
ChEMBL
CHEMBL1618279
Created by admin on Fri Dec 15 16:14:35 UTC 2023 , Edited by admin on Fri Dec 15 16:14:35 UTC 2023
PRIMARY
PUBCHEM
204104
Created by admin on Fri Dec 15 16:14:35 UTC 2023 , Edited by admin on Fri Dec 15 16:14:35 UTC 2023
PRIMARY
NCI_THESAURUS
C76489
Created by admin on Fri Dec 15 16:14:35 UTC 2023 , Edited by admin on Fri Dec 15 16:14:35 UTC 2023
PRIMARY
EVMPD
SUB32092
Created by admin on Fri Dec 15 16:14:35 UTC 2023 , Edited by admin on Fri Dec 15 16:14:35 UTC 2023
PRIMARY
INN
8415
Created by admin on Fri Dec 15 16:14:35 UTC 2023 , Edited by admin on Fri Dec 15 16:14:35 UTC 2023
PRIMARY
CAS
199463-33-7
Created by admin on Fri Dec 15 16:14:35 UTC 2023 , Edited by admin on Fri Dec 15 16:14:35 UTC 2023
PRIMARY
WIKIPEDIA
Revaprazan
Created by admin on Fri Dec 15 16:14:35 UTC 2023 , Edited by admin on Fri Dec 15 16:14:35 UTC 2023
PRIMARY
SMS_ID
100000124423
Created by admin on Fri Dec 15 16:14:35 UTC 2023 , Edited by admin on Fri Dec 15 16:14:35 UTC 2023
PRIMARY
Related Record Type Details
Structure of REVAPRAZAN HYDROCHLORIDE
SALT/SOLVATE -> PARENT
H+/K+ ATPASE
TARGET -> INHIBITOR
Related Record Type Details
Structure of REVAPRAZAN
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966